This research in this major analysis demonstrates that the claimed benefits of genetically modified pharmaceuticals are speculative at best, and the risks and potential costs of contamination are too high.
This research in this major analysis demonstrates that the claimed benefits of genetically modified pharmaceuticals are speculative at best, and the risks and potential costs of contamination are too high.